Most cited papers from Hospital Alto Deba

Hospital Alto Deba

What are the most cited papers from Hospital Alto Deba?

The most cited paper from Hospital Alto Deba is "Modeling Using Discrete Event Simulation" (Jonathan D. Karnon, James E. Stahl, Alan Brennan et al., 2012), with 338 citations. Next come "Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias" (312) and "Trail Making Test in traumatic brain injury, schizophrenia, and normal ageing: Sample comparisons and normative data" (243).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 29 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Modeling Using Discrete Event Simulation Jonathan D. Karnon, James E. Stahl, Alan Brennan et al. · Medical Decision Making Open access	Sep 2012	338
2	Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias Julio López Bastida, Juan Oliva, Fernando Antoñanzas et al. · Gaceta Sanitaria Open access	3 Dec 2009	312
3	Trail Making Test in traumatic brain injury, schizophrenia, and normal ageing: Sample comparisons and normative data José Antonio Periañez, M RIOSLAGO, José Manuel Rodríguez-Sánchez et al. · Archives of Clinical Neuropsychology	2 Mar 2007	243
4	Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4 Jonathan D. Karnon, James E. Stahl, Alan Brennan et al. · Value in Health Open access	Sep 2012	242
5	Spanish recommendations on economic evaluation of health technologies Julio López‐Bastida, Juan Oliva, Fernando Antoñanzas et al. · The European Journal of Health Economics	19 Apr 2010	240
6	‘Dignity therapy’, a promising intervention in palliative care: A comprehensive systematic literature review Marina Martínez, María Arantzamendi, Alazne Belar et al. · Palliative Medicine ReviewOpen access	26 Aug 2016	220
7	Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice Monica Calderón-Goercke et al. · Seminars in Arthritis and Rheumatism Open access	5 Jan 2019	109
8	The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea Javier Mar, José-Ramón Rueda, J. Durán-Cantolla et al. · European Respiratory Journal Open access	Mar 2003	109
9	Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis M. Isabel Lucena, Neil Kaplowitz, Hacibe Hallal et al. · Journal of Hepatology	20 Feb 2011	108
10	Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance? Javier Mar, Fernando Rodríguez‐Artalejo · Journal of Hypertension	2001	108
11	Determinants of Informal Care, Burden, and Risk of Burnout in Caregivers of Stroke Survivors Juan Oliva-Moreno, Luz María Peña-Longobardo, Javier Mar et al. · Stroke	28 Nov 2017	102
12	Mediterranean Diet and Risk of Dementia and Alzheimer’s Disease in the EPIC-Spain Dementia Cohort Study María Encarnación Andreu-Reinón, María Dolores Chirlaque, Diana Gavrila et al. · Nutrients Open access	22 Feb 2021	98
13	Economic impact of patients admitted to stroke units in Spain CONOCES Investigators Group, José Álvarez‐Sabín, Manuel Quintana et al. · The European Journal of Health Economics	15 Apr 2016	98
14	Expert‐based drug lists to measure anticholinergic burden: similar names, different results Unax Lertxundi, Saioa Domingo‐Echaburu, Rafael Hernández et al. · Psychogeriatrics Open access	Mar 2013	96
15	Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients Yago González‐Lama et al. · Alimentary Pharmacology & Therapeutics Open access	3 Jul 2011	88
16	Antipsychotics and seizures: Higher risk with atypicals? Unax Lertxundi, Rafael Hernández, Juan Medrano et al. · Seizure Open access	9 Nov 2012	86
17	The impact of acquired brain damage in terms of epidemiology, economics and loss in quality of life Javier Mar, Arantzazu Arrospide, José María Begiristáin et al. · BMC Neurology Open access	18 Apr 2011	83
18	Spanish National Hip Fracture Registry (RNFC): analysis of its first annual report and international comparison with other established registries on behalf of the participants in the RNFC, Cristina Ojeda‐Thies, Pilar Sáez-López et al. · Osteoporosis International	23 Mar 2019	82
19	Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine Javier Arístegui, E. Bernaola, Itziar Pocheville et al. · European Journal of Clinical Microbiology & Infectious Diseases	20 Apr 2007	71
20	Unidimensional 12-Item Zarit Caregiver Burden Interview for the Assessment of Dementia Caregivers’ Burden Obtained by Item Response Theory Javier Gutiérrez Ballesteros, Borja Santos, Eduardo González–Fraile et al. · Value in Health Open access	4 Oct 2012	69
21	Cost-Effectiveness Analysis of Thrombolytic Treatment for Stroke Javier Mar, José María Begiristáin, Arantza Arrazola · Cerebrovascular Diseases	2005	69
22	A randomized trial to assess the efficacy of a psychoeducational intervention on caregiver burden in schizophrenia Manuel Martı́n-Carrasco, Paola Fernández-Catalina, Ana I. Domínguez-Panchón et al. · European Psychiatry	2016	67
23	Effectiveness of a Psychoeducational Intervention Group Program in the Reduction of the Burden Experienced by Caregivers of Patients With Dementia Manuel Martı́n-Carrasco, Ana I. Domínguez-Panchón, Eduardo González–Fraile et al. · Alzheimer Disease & Associated Disorders	11 Oct 2013	66
24	Environmental pollution with psychiatric drugs Julene Escudero Argaluza, Saioa Domingo‐Echaburu, Gorka Orive et al. · World Journal of Psychiatry Open access	15 Oct 2021	63
25	El síndrome de apneas-hipopneas durante el sueño en España. Disponibilidad de recursos para su diagnóstico y tratamiento en los hospitales del Estado español Joaquín Durán‐Cantolla, Javier Mar, G. de la Torre Muñecas et al. · Archivos de Bronconeumología	2004	63
26	Burden of First Osteoporotic Hip Fracture in Spain: A Prospective, 12-Month, Observational Study on behalf of the PROA investigators, José Ramón Caeiro, Agustí Bartra et al. · Calcified Tissue International Open access	13 Oct 2016	61
27	Needle-guided intrascleral fixation of posterior chamber intraocular lens for aphakia correction Iñaki Rodríguez-Agirretxe, Arantxa Acera-Osa, Marta Ubeda-Erviti · Journal of Cataract & Refractive Surgery	Dec 2009	61
28	Drug pollution & Sustainable Development Goals Saioa Domingo‐Echaburu, Liliana M. Dávalos, Gorka Orive et al. · The Science of The Total Environment	2 Aug 2021	59
29	Inequalities in health-related quality of life according to age, gender, educational level, social class, body mass index and chronic diseases using the Spanish value set for Euroquol 5D-5L questionnaire Arantzazu Arrospide, Mónica Machón, Juan Manuel Ramos-Goñi et al. · Health and Quality of Life Outcomes Open access	18 Apr 2019	59
30	Antipsychotics as environmental pollutants: An underrated threat? J. Escudero, José Luis García-Muñoz, Teresa Morera‐Herreras et al. · The Science of The Total Environment Open access	10 Jan 2021	57
31	UPRIGHT, a resilience-based intervention to promote mental well-being in schools: study rationale and methodology for a European randomized controlled trial Carlota Las Hayas et al. · BMC Public Health Open access	29 Oct 2019	56
32	In-hospital care, complications, and 4-month mortality following a hip or proximal femur fracture: the Spanish registry of osteoporotic femur fractures prospective cohort study Daniel Prieto‐Alhambra et al. · Archives of Osteoporosis Open access	14 Sep 2018	55
33	Budget Impact Analysis of Thrombolysis for Stroke in Spain: A Discrete Event Simulation Model Javier Mar, Arantzazu Arrospide, Mercè Comas · Value in Health Open access	8 Oct 2009	55
34	Projecting Burden of Dementia in Spain, 2010–2050: Impact of Modifying Risk Factors Myriam Soto‐Gordoa, Arantzazu Arrospide, Fermín Moreno-Izco et al. · Journal of Alzheimer s Disease	Oct 2015	55
35	Cost-Effectiveness of the Use of Biomarkers in Cerebrospinal Fluid for Alzheimer's Disease Cristina Valcárcel‐Nazco, Lilisbeth Perestelo‐Pérez, José Luís Molinuevo et al. · Journal of Alzheimer s Disease	16 Sep 2014	55
36	Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C Ramón San Miguel, Vicente Gimeno‐Ballester, Antonio Blázquez et al. · Gut	13 Oct 2014	54
37	Impaired L1 and executive control after left basal ganglia damage in a bilingual Basque–Spanish person with aphasia Daniel Adrover‐Roig, Nekane Galparsoro-Izagirre, Karine Marcotte et al. · Clinical Linguistics & Phonetics	31 Mar 2011	52
38	Analysis of outcomes of emergency general and gastrointestinal surgery during the COVID-19 pandemic Javier Osorio et al. · British journal of surgery Open access	27 Jul 2021	46
39	Health care costs of breast, prostate, colorectal and lung cancer care by clinical stage and cost component Oliver Ibarrondo, Garbiñe Lizeaga, José Miguel Martínez-Llorente et al. · Gaceta Sanitaria Open access	18 Feb 2021	44
40	Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients Antonio Blázquez-Pérez, Ramón San Miguel, Javier Mar · PharmacoEconomics	2 Sep 2013	39
41	Medication errors in Parkinson's disease inpatients in the Basque Country Unax Lertxundi, Arantxa Isla, Maria Ángelés Solinís et al. · Parkinsonism & Related Disorders	4 Jan 2017	38
42	Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain on behalf of CONOCES Investigators Group, Javier Mar, Jaime Masjuán et al. · Health and Quality of Life Outcomes Open access	16 Mar 2015	38
43	High mortality rate following periprosthetic femoral fractures after total hip arthroplasty. A multicenter retrospective study Jesús Moreta, Iker Uriarte, Iñigo Bidea et al. · Injury	29 Jan 2021	36
44	Impact Assessment of an Innovative Integrated Care Model for Older Complex Patients with Multimorbidity: The CareWell Project Maider Mateo‐Abad et al. · International Journal of Integrated Care Open access	22 May 2020	36
45	Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model Isabel Idígoras, Arantzazu Arrospide, Isabel Portillo et al. · BMC Public Health Open access	Aug 2017	35
46	Cost Analysis of Real-Time Polymerase Chain Reaction Microbiological Diagnosis in Patients with Septic Shock Julián Álvarez, Javier Mar, Eduardo Varela-Ledo et al. · Anaesthesia and Intensive Care Open access	Nov 2012	35
47	Los modelos de Markov probabilísticos en la evaluación económica de tecnologías sanitarias: una guía práctica Javier Mar, Fernando Antoñanzas, Roberto Pradas et al. · Gaceta Sanitaria Open access	21 Apr 2010	35
48	Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice. Monica Calderón-Goercke et al. · PubMed	9 Sep 2020	34
49	Regional variability in changes in the incidence of hip fracture in the Spanish population (2000–2012) Íñigo Etxebarría-Foronda, Arantzazu Arrospide, Myriam Soto‐Gordoa et al. · Osteoporosis International Open access	8 Jan 2015	34
50	Anticholinergic burden in Parkinson’s disease inpatients Unax Lertxundi, Arantxa Isla, Maria Ángelés Solinís et al. · European Journal of Clinical Pharmacology	7 Aug 2015	34

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.